Back to search results

Charcot-Marie-Tooth Disease Biological Sample Collection

This research study, conducted by the New York Stem Cell Foundation, is collecting biological samples like skin, blood, and saliva from people with Charcot-Marie-Tooth disease (CMT) and healthy volunteers. The goal is to create stem cells from these samples and store them in a biobank for future research. Researchers will also perform genetic testing to understand more about CMT. By studying these cells and genetic information, scientists hope to find new treatments or even cures for CMT. This study is open to individuals aged 5 years and older. The main goal is to build this biobank of samples.

Study design
This is an observational study with a planned enrollment of 50 participants. It is not a clinical trial testing a new treatment.
What's involved
You would complete health questionnaires, provide a skin and/or blood sample, and give a saliva sample. There might be future follow-up for more information or other studies.
Compensation
Not stated in the trial record.
Follow-up
Not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06203093

Charcot-Marie-Tooth Disease (CMT) Biological Sample Collection for IPSC Generation and Biobanking

UNKNOWN
Not specifiedAges 5+Observational
New York Stem Cell Foundation Research Institute
~50 participants
Updated 2025-03-03 on ClinicalTrials.gov
What's tested:Biological Sample Collection

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Biobank
Measured over Baseline

Conditions

Charcot-Marie-Tooth Disease
Healthy

Explore related trials

Charcot-Marie-Tooth DiseaseHealthy

Where it's being run

1 sites across 1 states
New York1

Study leadership

  • Laura Andres-Martin · PRINCIPAL_INVESTIGATOR · New York Stem Cell Foundation Research Institute

Who to contact

Clinical Research Office
[email protected]
212-927-1801
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age 5 years or older.
Diagnosis of Charcot-Marie-Tooth (CMT) disease or healthy controls.
Adults must provide written informed consent unless physical limitations preclude signing.
Minors undergoing skin collection for research purposes must have a CMT diagnosis and must participate with parent/guardian consent.
Minors undergoing blood and/or saliva collection for research purposes or who transfer biological samples from a procedure outside the research may have a CMT diagnosis or serve as a healthy control and may participate with parent/guardian consent.

Exclusion

Wards of the state.
For prospective skin samples: history of keloid formation, coagulation disorder, allergy to the anesthetic, or anticoagulation use that precludes sample collection.
For prospective blood samples: coagulation disorder or other medical conditions that increase the risks associated with blood collection.
For all prospective sample collections: Subjects who refuse to adhere to NYSCF's and/or a collaborating site's safety protocols will be excluded. Subjects with an AIDS diagnosis and CD4 count of less than 200 cells per microliter of blood will be excluded due to increased risk of infection.

What this trial measures

  • BiobankBaseline

    Establishment of a bank of stem cell lines and associated information to advance understanding of the biology, etiology, manifestations, progression, risk factors, genetic underpinnings, and treatment of Charcot-Marie-Tooth diseases.